Dr. Espandar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
203 Lothrop St
7TH floor Eeins
Pittsburgh, PA 15213Phone+1 412-647-2214Fax+1 412-647-0997
Education & Training
- Tulane UniversityResidency, Ophthalmology, 2009 - 2012
- Tulane UniversityInternship, Transitional Year, 2008 - 2009
- Tehran University of Medical Sciences School of MedicineClass of 2000
Certifications & Licensure
- PA State Medical License 2014 - 2024
- NC State Medical License 2012 - 2015
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK Start of enrollment: 2015 Feb 01
Publications & Presentations
PubMed
- 21 citationsA Narrative Review of Microsporidial Infections of the CorneaMajid Moshirfar, Shaan N. Somani, Kathryn M. Shmunes, Ladan Espandar, Nikhil S. Gokhale
Ophthalmology and Therapy. 2020-03-10 - 147 citationsTopical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.Stephen C. Pflugfelder, Mina Massaro-Giordano, Victor L. Perez, Pedram Hamrah, Sophie X. Deng
Ophthalmology. 2020-01-01 - Consultation Section: Cataract. October consultation #4.Ladan Espandar
Journal of Cataract and Refractive Surgery. 2019-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: